Prevention and treatment of in-stent restenosis

Journal of Cardiovascular Surgery

Volumn 51, Issue 4, 2010, Pages 591-598

  Bosiers, M ^a   Deloose, K ^a   Keirse, K ^b   Verbist, J ^b   Peeters, R ^b  

^a AZ St Blasius ^*  (Belgium)

^b IMELDA HOSPITAL   (Belgium)

Author keywords

Blood vessels, physiology; Coronary restenosis; Stents

Indexed keywords

NITINOL; PACLITAXEL; RAPAMYCIN;

ATHERECTOMY; BALLOON CATHETER; BARE METAL STENT; CELL PROLIFERATION; DRUG ELUTING STENT; HUMAN; IN-STENT RESTENOSIS; LIMB ISCHEMIA; POPLITEAL ARTERY; PREVALENCE; REVIEW; SMOOTH MUSCLE FIBER; SUPERFICIAL FEMORAL ARTERY;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; HUMANS; PROSTHESIS DESIGN; RECURRENCE; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 78649277789     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Payne MM. Charles Theodore Dorter, The Father of Intervention". Tex Heart Inst J 2001;28:28-38.
2. Grüntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet 1978;1(8058):263.
3. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45 Suppl S:S5-67
4. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996;94: 1247-54;
5. White GH, Liew SC, Waugh RC, Stephen MS, Harris JP, Kidd J et al. Early outcome and intermediate follow-up of vascular stents in the femoral and popliteal arteries without long-term anticoagulation. J Vasc Surg 1995;21:270-9.
6. Henry M, Amor M, Beyar R, Henry I, Porte JM, Mentre B et al. Clinical experience with a new nitinol self-expanding stent in peripheral arteries. J Endovasc Surg 1996;3:369-79.
7. Gray BH, Sullivan TM, Childs MB, Young JR, Olin JW. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 1997;25:74-83.
8. Bosiers M, Torsello G, Gissler HM, Ruef J, Müller-Hülsbeck S, Jahnke T et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther 2009;16:261-9.
9. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31(1 Pt 2):S1-S296.
10. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-88.
11. Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther 2005;12:6-12.
12. Scheinert D, Scheinert S, Sax J, Piorkowski C, Bräunlich S, Ulrich M et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5.
13. Serruys PW, Kutryk MJB, Ong ATL. Coronary artery stents. New Engl J Med 2006;354:483-95.
14. Duda S, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16:331-8.
15. Duda S, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V et al. Drug-eluting and bare nitinol stents for the treatment of athero- sclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 2006;13:701-10.
16. Katzen B. The Resilient Trial 12-Month Analysis. Transcatheter Cardiovascular Therapeutics 2007. Washington Conference Center, Washington DC; Oct 23, 2007.
17. Schillinger M. Results from the Astron trial. Paris Course on Revascularisation (PCR), Barcelona, Spain, 2008.
18. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-88.
19. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 2006;13:701-10.
20. Lammer J. First-in-human clinical trial of nitinol self-expanding everolimus-eluting stent for prevention of restenosis following infrainguinal endovascular intervention: The STRIDES trial. Presented at Cardiovascular and Interventional Radiological Society of Europe (CIRSE) meeting, Lisbon, Portugal, 2009.
21. Dake M. Interim report on the Zilver® PTX™ clinical trial. Presented at International Symposium on Endovascular Therapy (ISET), Hollywood, Florida, US, 2007.
22. Sapoval M. Interim report on the effectiveness of the Zilver® PTX™ drug-eluting stent in long SFA lesions. Presented at Cardiovascular and Interventional Radiological Society of Europe (CIRSE) meeting, Lisbon, Portugal, 2009.
23. Schlager O, Dick P, Sabeti S, Amighi J, Mlekusch W, Minar E et al. Long-segment SFA stenting - the dark sides: in-stent restenosis, clinical deterioration and stent fractures. J Endovasc Ther 2005;12:676-84.
24. Karthik S, Kessel DO. Cryoplasty - where is the evidence? Acta Chir Belg 2007;107:500-3.
25. Dick P, Sabeti S, Mlekusch W, Amighi J, Sabeti S, Schlager O et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery stenosis: initial experience. Radiology 2008;248:297-302.
26. Zeller T, Frank U, Bürgelin K, Schwarzwälder U, Horn B, Flügel PC et al. Long-term results after recanalization of acute and subacute thrombotic occlusions of the infra-aortic arteries and bypass-grafts using a rotational thrombectomy device. Röfo Fortschr Geb Roentgenstr Neue Bildgeb Verfahr 2002;174:1559-65.
27. Zeller T, Sixt S, Schwarzwälder U, Schwarz T, Frank U, Bürgelin K et al. Two-year results after directional atherectomy of infrapopliteal arteries with the SilverHawk device. J Endovasc Ther 2007;14:232-40.
28. Saxon RR, Coffman JM, Gooding JM, Ponec DJ. Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions. J Vasc Interv Radiol 2007;18:1341-9.
29. Ansel GM, Lumsden AB. Evolving modalities for femoropopliteal interventions. J Endovasc Ther 2009;16(Suppl II):1182-97.
30. Ovrum E, Tangen G, Oystese R, Ringdal MA, Istad R. Comparison of two heparin-coated extracorporal circuits with reduced systemic anticoagulation in routine coronary bypass operations. J Thoracic Cardiovasc Surg 2001;121:324-30.
31. Kocsis JF, Llanos G, Holmer E. Heparin-coated stents. J Long Term Eff Med Implants 2000;10:19-45.
32. Dorrucci V, Griselli F, Petralia G, Spinamano L, Adornetto R. Heparin-bonded expanded polytetrafluoroethylene grafts for infragenicular bypass in patients with critical limb ischemia: 2-year results. J Cardiovasc Surg (Torino) 2008;49:145-9.
33. Peeters P, Verbist J, Deloose K, Bosiers M. Will heparin-bonded PTFE replace autologous venous conduits in infrapopliteal bypass? J Vasc Endovasc Surg 2008;15:143-8.
34. Hugl B, Nevelsteen A, Daenens K. PEPE II - A multicenter study with an end-point heparin-bonded expanded polytetrafluoroethylene vascular graft for above and below the knee bypass surgery: determinants of patency. J Cardiovasc Surg (Torino) 2009;50:195-203.
35. Kazemi S, Djelmami-Hani M, Tumuluri R. VIABAHN Stent-Graft for Treatment of IRS in Femoropopliteal Vascular Occlusive Disease, Procedural Outcome and One-Year Follow Up. TCT 2006, Washington, US.
36. Ansel MG, Botti CF, Taylor M, Silver MJ. A 2007 update on treating nitinol stent restenosis. Endovascular Today 2007;80-2.
37. Zeller T, Lottes A. Interim report on the Zilver PTX™ for treating in-stent restenosis. Presented at Cardiovascular and Interventional Radiological Society of Europe (CIRSE) meeting, Lisbon, Portugal, 2009.
38. Henry TD, Schwartz RS, Hirsch AT. "POBA Plus": Will the Balloon Regain Its Luster? Circulation 2008;118:1309-11.
39. Waksman R,. Pakala R. Drug-eluting balloon: the comeback kid? Circ Cardiovasc Intervent 2009;2:352-8.
40. Marzullo R, Aprile A, Clementi F, Stella P, Modena MG, Sangiorgi GM. Paclitaxel eluting balloon from bench to bedside. Minerva Cardioangiol 2009;57:597-609.
41. Zimarino M, De Caterina R. Drug-eluting balloons for percutaneous coronary interventions. Thromb Haemost 2009;101:9-11.
42. Tepe G, Schmitmeier S, Speck U, Schnorr B, Kelsch B, Scheller B. Advances on drug-coated balloons. J Cardiovasc Surg 2010;51:125-43.
43. Diehm N.A. Drug Eluting Balloons. Tech Vasc Interventional Rad 2010;13:59-63.
44. Axel D.I. Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration in vitro and in vivo Using Local Drug Delivery. Circulation 1997;96:636-45.
45. Herdeg C, Oberhoff M, Baumbach A, Blattner A, Küttner A, Schröder S et al. Visualization and comparison of drug effects after local paclitaxel delivery with different catheter types. Basic Res Cardiol 1999;94:454-63.
46. Axel DI, Kunert W, Göggelmann C, Oberhoff M, Herdeg C, Küttner A et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997;96:636-45.
47. Herdeg C, Oberhoff M, Baumbach A, Blattner A, Axel DI, Schröder S et al. Local Paclitaxel Delivery for the Prevention of Restenosis: Biological Effects and Efficacy in vivo. J Am Coll Cardiol 2000;35: 1969-76.
48. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008;358:689-99.
49. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U et al. Treatment of Coronary IRS with a Paclitaxel-Coated Balloon Catheter. N Engl J Med 2006;355:2113-24.
50. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U et al. Two year follow-up after treatment of coronary ISR witha paclitaxelcoated balloon catheter. Clin Res Cardiol 2008;97:773-81.
51. Scheller B. PACCOCATH 1 and 2: a prospective, randomized trial of a paclitaxel-eluting balloon in in-stent restenosis: 2-year results. Transcatheter Cardiovascular Therapeutics (TCT), Washington DC, USA, 2007.
52. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009;119:2986-94.